Westpac Banking Corp’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-71,869
Closed -$6.34M 869
2021
Q1
$6.34M Buy
71,869
+2,500
+4% +$232K 0.07% 351
2020
Q4
$6.64M Sell
69,369
-4,600
-6% -$474K 0.08% 336
2020
Q3
$8.4M Hold
73,969
0.11% 233
2020
Q2
$7.32M Sell
73,969
-11,048
-13% -$882K 0.11% 247
2020
Q1
$5.47M Sell
85,017
-37,500
-31% -$2.63M 0.09% 265
2019
Q4
$7.3M Buy
122,517
+15,000
+14% +$925K 0.09% 303
2019
Q3
$6.34M Buy
107,517
+16,400
+18% +$1.05M 0.09% 316
2019
Q2
$5.88M Sell
91,117
-7,000
-7% -$452K 0.09% 296
2019
Q1
$6.23M Sell
98,117
-71,900
-42% -$3.78M 0.1% 267
2018
Q4
$6.46M Buy
170,017
+28,700
+20% +$1.01M 0.11% 256
2018
Q3
$6.05M Buy
+141,317
New +$4.94M 0.1% 273

Other funds holding TNDM

Westpac Banking Corp's TNDM Position: Q2 2021 in Review

Westpac Banking Corp sold out of Tandem Diabetes Care (TNDM) in Q2 2021, closing a stake of 71,869 shares — an estimated $6.34M sold.

Westpac Banking Corp first reported a position in TNDM in Q3 2018 and held it in 11 quarters. The position peaked at $8.4M in Q3 2020. 303 funds tracked by Wall St. Rank hold TNDM as of Q2 2021.

  • Westpac Banking Corp reported no remaining Tandem Diabetes Care position as of Q2 2021 after selling out during the quarter.
  • Westpac Banking Corp sold 71,869 Tandem Diabetes Care shares in Q2 2021, an estimated $6.34M.
  • Westpac Banking Corp first reported a position in Tandem Diabetes Care in Q3 2018 and held it in 11 quarters.
  • Westpac Banking Corp's Tandem Diabetes Care position peaked at $8.4M in Q3 2020.
  • 303 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2021.

Based on Westpac Banking Corp's 13F filing for Q2 2021, filed 11 Aug 2021.